Meeting Bandi

On 24/25 October 1994 I attended in Brussels a meeting of the drug-device-borderline issues working group of the European Commission. One of the subjects on the agenda was whether to classify hyaluronan containing products for medical use as drugs or as medical devices under the new European Medical Devices Directive 93/42/EEC (MDD). Pharmacia was interested … Continue reading Meeting Bandi